We are 2-Methyltetrahydrofuran CAS:96-47-9 manufacturer and supplier in China, Pls send inquiry of to email@example.com of visit www.nbinno.com our official website should you have any interests
Product Name: 2-Methyltetrahydrofuran
Synonym: 2-Methyl Tetrahydrofuran; 2-Methyl-THF; METHF; Intermediate of Chloroquine Phosphate
Cas No.: 96-47-9
EINECS No.: 202-507-4
HS Code: 2932190090
UN No.: 2536
Hazard class: 3 categories
Packing level: Class II
It is mainly used as a replacement for THF in specialized applications for its better performance, such as to obtain higher reaction temperatures, or easier separations (as, unlike THF, it is not miscible with water). It is derived from furfural and is usable as a biofuel.
Intermediate of Chloroquine Phosphate.
2-methyltetrahydrofuran is used as a green solvent. It can replace tetrahydrofuran as a Grignard reaction solvent, and can also replace benzene, toluene, chloroform and other solvents. It is widely used in the synthesis of perfumes, new materials, etc.
170kgs/drum, can also be packaged according to customer requirements.
Store in a cool, ventilated warehouse.
Keep away from fire and heat.
The temperature should not exceed 37 °C.
Related News: “With early evidence of clinical activity for our off-the-shelf, iPSC-derived NK cell programs, we are excited to lead in bringing next-generation CAR T-cell therapies to patients and plan to submit an IND for FT819 in the first half of 2020.”Ácido [4- (N-fenilanilino) fenil] borónico CAS:201802-67-7 The mode of cooperation between domestic API companies and large international companies can lower the export threshold.5-bromo-4-fluoro-2-metilanilina CAS:627871-16-3 The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it.63074-07-7 The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it.Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS).